scholarly journals From Sandbox to Pandemic: Agile Reform of Canadian Drug Regulation

Author(s):  
Ipek Eren Vural ◽  
Matthew Herder ◽  
Janice E. Graham
Keyword(s):  
2016 ◽  
Vol 21 (11) ◽  
pp. 1806-1813 ◽  
Author(s):  
Peter Papathanasiou ◽  
Laurent Brassart ◽  
Paul Blake ◽  
Anna Hart ◽  
Lel Whitbread ◽  
...  

Science ◽  
2002 ◽  
Vol 296 (5567) ◽  
pp. 425m-425
Keyword(s):  

BMJ ◽  
2007 ◽  
Vol 334 (7588) ◽  
pp. 290-291 ◽  
Author(s):  
Rebecca Coombes
Keyword(s):  

The Lancet ◽  
1984 ◽  
Vol 323 (8379) ◽  
pp. 718-719
Keyword(s):  

2018 ◽  
Vol 2 (3) ◽  
pp. 43-47
Author(s):  
Rajkumar Gupta

The pharmaceutical products are very much driven by the drug regulation imposed by ministry of health in individual countries. The basic facts on regulations is that they are mandatory and noncompliant are punishable under the law. Further, compliance is not a one time job but it is an exercise to be performed over the life cycle of the drug products. It starts from development of the products and continues till the product is in market. The information, registration, permission and extensions/withdrawals are the primary regulatory requirements for the drug products. The main focus of drug regulations is to check that safety, quality and efficacy of the drug products over its lifecycle.


Sign in / Sign up

Export Citation Format

Share Document